» Authors » Severo Campione

Severo Campione

Explore the profile of Severo Campione including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 216
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferriero R, Bruno G, Padula A, Pisano S, Boffa I, Gargaro M, et al.
Nat Commun . 2025 Mar; 16(1):2118. PMID: 40064861
Liver fibrosis, characterized by scar tissue accumulation due to liver injury, poses significant barriers to liver-targeted gene therapy. Current clinical trials exclude patients with fibrosis, as intact liver architecture is...
2.
Acanfora G, Iaccarino A, Cerbelli B, Di Cristofano C, Bellevicine C, Barberis M, et al.
Cancer Cytopathol . 2025 Feb; 133(3):e70003. PMID: 39992702
Introduction: The aim of this project is to assess interobserver agreement for programmed death-ligand 1 (PD-L1) scoring on of non-small cell lung cancer (NSCLC) on cytological specimens in a large-scale...
3.
Pisapia P, Iaccarino A, De Luca C, Pepe F, Russo G, Nacchio M, et al.
Pathologica . 2025 Jan; 116(5):310-319. PMID: 39748713
Objective: ALK, ROS1, NTRK, and RET gene fusions and MET exon 14 skipping alterations represent fundamental predictive biomarkers for advanced non-small cell lung cancer (NSCLC) patients to ensure the best...
4.
Luca S, Accardo M, Campione S, Franco R
Explor Target Antitumor Ther . 2024 Jul; 5(3):465-476. PMID: 38966177
Thymic epithelial tumors (TETs) are rare malignant neoplasms arising in the thymus gland. Nevertheless, TETs, including thymomas (TMs), thymic carcinomas (TCs), and thymic neuroendocrine neoplasms (TNENs), are the most common...
5.
Luce A, Abate M, Scognamiglio G, Montella M, Iervolino D, Campione S, et al.
J Transl Med . 2024 May; 22(1):521. PMID: 38816839
Background: Primary malignant brain tumours are more than one-third of all brain tumours and despite the molecular investigation to identify cancer driver mutations, the current therapeutic options available are challenging...
6.
Caputo C, Falco M, Grimaldi A, Lombardi A, Miceli C, Cocule M, et al.
Cancers (Basel) . 2024 Feb; 16(4). PMID: 38398215
Pancreatic ductal adenocarcinoma (PDAC), a neoplasm of the gastrointestinal tract, is the most common pancreatic malignancy (90%) and the fourth highest cause of cancer mortality worldwide. Surgery intervention is currently...
7.
Padula A, Spinelli M, Nusco E, Bujanda Cundin X, Capolongo F, Campione S, et al.
JCI Insight . 2023 Sep; 8(21). PMID: 37707949
Application of classic liver-directed gene replacement strategies is limited in genetic diseases characterized by liver injury due to hepatocyte proliferation, resulting in decline of therapeutic transgene expression and potential genotoxic...
8.
Martino A, Di Serafino M, Orsini L, Giurazza F, Fiorentino R, Crolla E, et al.
World J Gastroenterol . 2023 Aug; 29(27):4222-4235. PMID: 37545636
Non-variceal upper gastrointestinal bleeding (NVUGIB) is a common gastroenterological emergency associated with significant morbidity and mortality. Gastroenterologists and other involved clinicians are generally assisted by international guidelines in its management....
9.
Altieri B, La Salvia A, Modica R, Marciello F, Mercier O, Filosso P, et al.
J Pers Med . 2023 Feb; 13(2). PMID: 36836564
Background: Large Cell Neuroendocrine Carcinoma (LCNEC) is a rare subtype of lung cancer with poor clinical outcomes. Data on recurrence-free survival (RFS) in early and locally advanced pure LCNEC after...
10.
Luca S, Zannini G, Morgillo F, Della Corte C, Fiorelli A, Marino F, et al.
Expert Rev Anticancer Ther . 2023 Feb; 23(3):265-277. PMID: 36772823
Introduction: An accurate histological evaluation of invasive lung adenocarcinoma is essential for a correct clinical and pathological definition of the tumour. Different grading systems have been proposed to predict the...